Travis Hardcastle, who oversees cell line products at Horizon Discovery, explains how the company’s nearhaploid cell models are enabling new types of biomedical discoveries. What’s so special ...

Dose response curves for cells treated with ALK inhibitors crizotinib and ceritinib (Figure 3 A, B) showed that the isogenic A549 EML4-ALK cell line has selective drug sensitivity to ALK ...